Female preponderance of Parkinson's disease in Japan

Neuroepidemiology

Volumn 21, Issue 6, 2002, Pages 292-296

  Kimura, H ^c   Kurimura, M ^c   Wada, M ^c   Kawanami, T ^c   Kurita, K ^c   Suzuki, Y ^c   Katagiri, T ^a   Daimon, M ^c   Kayama, T ^c   Kato, Takeo ^b  

^a Yamagata Prefectural Kahoku Hospital   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c NONE

Author keywords

Estrogen; Gender; Parkinson's disease; Prevalence; Sex; Yamagata, Japan

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EUROPE; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION RESEARCH; PREVALENCE; SEX RATIO; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; SEX RATIO;

EID: 0036967931     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065527     Document Type: Article

References (22)

1. Zhang ZX, Roman GC: Worldwide occurrence of Parkinson's disease: An updated review. Neuroepidemiology 1993;12:195-208.
2. Milanov I, Kmetski TS, Lyons KE, Koller WC: Prevalence of Parkinson's disease in Bulgarian gypsies. Neuroepidemiology 2000;19:206-209.
3. Kuopio A-M, Marttila RJ, Helenius H, Rinne UK: Changing epidemiology of Parkinson's disease in southwestern Finland. Neurology 1999;52:302-308.
4. Bower JH, Maraganore DM, McDonnell SK, Rocca WA: Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
5. Bower JH, Maraganore DM, McDonnell SK, Rocca WA: Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease. Mov Disord 2000;15:819-825.
6. Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto E, Grigoletto F, Amaducci L, Inzitari D: Parkinson's disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men. Neurology 2000;55: 1358-1363.
7. Schrag A, Ben-Shlomo Y, Quinn NP: Cross-sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London. BMJ 2000;321:21-22.
8. Milanov I, Kmetska K, Karakolev B, Nedialkov E: Prevalence of Parkinson's disease in Bulgaria. Neuroepidemiology 2001;20:212-214.
9. Miller DB, Ali SF, O'Callaghan JP, Laws SC: The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann NY Acad Sci 1998;844:153-165.
10. Sawada H, Ibi M, Kihara T, Urushitani M, Akaike A, Shimohama S: Estradiol protects mesencephalic neurons from oxidative stress-induced neuronal death. J Neurosci Res 1998; 54:707-719.
11. Sawada H, Ibi M, Kihara T, Urushitani M, Honda K, Nakanishi M, Akaike A, Shimohama S: Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons. FASEB J 2000;14:1202-1214.
12. Green PS, Simpkins JW: Neuroprotective effects of estrogens: Potential mechanisms of action. Int J Dev Neurosci 2000;18:347-358.
13. Marder K, Tang MX, Alforo B, Mejia H, Cote L, Jacobs D, Stern Y, Sano M, Mayeux R: Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology 1998;50:1141-1143.
14. Strijks E, Kremer JA, Horstink MW: Effects of female sex steroids on Parkinson's disease in postmenopausal women. Clin Neuropharmacol 1999;22:93-97.
15. Blanchet PJ, Fang J, Hyland K, Arnold LA, Mouradian MM, Chase TN: Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: A crossover study. Neurology 1999;13:91-95.
16. Tsang KL, Ho SL, Lo SK: Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology 2000;54:2292-2298.
17. Okada K, Kobayashi S, Tsunematsu T: Prevalence of Parkinson's disease in Izumo City, Japan. Gerontology 1990;36:340-344.
18. Kusumi M, Nakashima K, Harada H, Nakayama H, Takahashi K: Epidemiology of Parkinson's disease in Yonago City, Japan: Comparison with a study carried out 12 years ago. Neuroepidemiology 1996;15:201-207.
19. Moriwaka F, Tashiro K, Itoh K, Honma S, Okumura H, Kikuchi S, Hamada T, Kaneko S, Kurokawa Y: Prevalence of Parkinson's disease in Hokkaido, the northernmost island of Japan. Intern Med 1996;35:276-279.
20. Morioka S, et al: Regional differences in the incidence of Parkinson's disease in Wakayama, Japan (in Japanese). Abstr 10th Annu Meet Jpn Epidemiol Assoc, Yonago, Japan, 2000, p 90.
21. Session DR, Pearlstone MM, Jewelewicz R, Kelly AC: Estrogens and Parkinson's disease. Med Hypotheses 1994;42:280-282.
22. Kompoliti K, Comella CL, Jaglin JA, Leurgans S, Raman R, Goetz CG: Menstrual-related changes in motoric function in women with Parkinson's disease. Neurology 2000;55:1572-1575.